Real time stability and viability prediction of the anticancer BCG after lyophilization

References

• van Lingen AV, Witjes JA. Current intravesical therapy for non-muscle invasive bladder cancer. Expert Opin Biol Ther 2013;13:1371–85
   PubMed Web of Science ®Google Scholar
• Barocas DA, Globe DR, Colayco DC, et al. Surveillance and treatment of non-muscle-invasive bladder cancer in the USA. Adv Urol 2012;2012:421709
   PubMedGoogle Scholar
• Chade DC, Shariat SF, Dalbagni G. Intravesical therapy for urothelial carcinoma of the urinary bladder: a critical review. Int Braz J Urol 2009;35:640–50; discussion 51
   PubMed Web of Science ®Google Scholar
• Herr HW, Morales A. History of bacillus Calmette–Guerin and bladder cancer: an immunotherapy success story. J Urol 2008;179:53–6
   PubMed Web of Science ®Google Scholar
• WHO. Who recommendations for BCG. Clin Pediatr (Phila) 1976;15:175–83
   PubMedGoogle Scholar
• Miller R Jr, Goodner K. Studies on the stability of lyophilized BCG vaccine. Yale J Biol Med 1953;25:262–83
   PubMed Web of Science ®Google Scholar
• Ranganathan KS. The present position of freeze-dried BCG vaccine. Ind J Tub 1963;5:102–12
   Google Scholar
• Hozouri H, Norouzian D, Nafissi-Varcheh N, Aboofazeli R. Challenges to improve the stability and efficacy of an intravesical BCG product. Iran J Pharm Res 2014;13:143–50
   PubMed Web of Science ®Google Scholar
• Jin TH, Nguyen L, Qu T, Tsao E. Improved formulation and lyophilization cycle for rBCG vaccine. Vaccine 2011;29:4848–52
   PubMed Web of Science ®Google Scholar
• Elbein AD, Pan YT, Pastuszak I, Carroll D. New insights on trehalose: a multifunctional molecule. Glycobiology 2003;13:17R–27R
   PubMed Web of Science ®Google Scholar
• De Smet KA, Weston A, Brown IN, et al. Three pathways for trehalose biosynthesis in mycobacteria. Microbiology 2000;146:199–208
   PubMed Web of Science ®Google Scholar
• Crowe JH, Crowe LM, Oliver AE, et al. The trehalose myth revisited: introduction to a symposium on stabilization of cells in the dry state. Cryobiology 2001;43:89–105
   PubMed Web of Science ®Google Scholar
• Mahjub R, Radmehr M, Dorkoosh FA, et al. Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations. Drug Dev Ind Pharm 2014;40:1645–59
   PubMed Web of Science ®Google Scholar
• Crowe LM, Crowe JH, Rudolph A, et al. Preservation of freeze-dried liposomes by trehalose. Arch Biochem Biophys 1985;242:240–7
   PubMed Web of Science ®Google Scholar
• Crowe LM, Reid DS, Crowe JH. Is trehalose special for preserving dry biomaterials? Biophys J 1996;71:2087–93
   PubMed Web of Science ®Google Scholar
• Leslie SB, Israeli E, Lighthart B, et al. Trehalose and sucrose protect both membranes and proteins in intact bacteria during drying. Appl Environ Microbiol 1995;61:3592–7
   PubMed Web of Science ®Google Scholar
• Crowe JH. Trehalose as a “chemical chaperone”: fact and fantasy. Adv Exp Med Biol 2007;594:143–58
   PubMed Web of Science ®Google Scholar
• Jain NK, Roy I. Trehalose and protein stability. Curr Protoc Protein Sci 2010;Chapter 4:Unit 4.9
   Google Scholar
• Kaushik JK, Bhat R. Why is trehalose an exceptional protein stabilizer? An analysis of the thermal stability of proteins in the presence of the compatible osmolyte trehalose. J Biol Chem 2003;278:26458–65
   PubMed Web of Science ®Google Scholar
• Morgan CA, Herman N, White PA, Vesey G. Preservation of micro-organisms by drying; a review. J Microbiol Methods 2006;66:183–93
   PubMed Web of Science ®Google Scholar
• Wang W. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm 2000;203:1–60
   PubMed Web of Science ®Google Scholar
• Arguelles JC. Physiological roles of trehalose in bacteria and yeasts: a comparative analysis. Arch Microbiol 2000;174:217–24
   PubMed Web of Science ®Google Scholar
• Obayashi Y. Dried BCG vaccine. Monogr Ser World Health Organ 1955;28:1–220
   PubMedGoogle Scholar
• Tang X, Pikal MJ. Design of freeze-drying processes for pharmaceuticals: practical advice. Pharm Res 2004;21:191–200
   PubMed Web of Science ®Google Scholar
• Adams G. The principles of freeze-drying. Methods Mol Biol 2007;368:15–38
   PubMedGoogle Scholar
• Nail SL, Jiang S, Chongprasert S, Knopp SA. Fundamentals of freeze-drying. Pharm Biotechnol 2002;14:281–360
   PubMedGoogle Scholar
• Williams NA, Polli GP. The lyophilization of pharmaceuticals: a literature review. J Parenter Sci Technol 1984;38:48–59
   PubMedGoogle Scholar
• Perry SF. Freeze-drying and cryopreservation of bacteria. Mol Biotechnol 1998;9:59–64
   PubMed Web of Science ®Google Scholar
• McLellan MR, Day JG. Cryopreservation and freeze-drying protocols. Introduction. Methods Mol Biol 1995;38:1–5
   PubMedGoogle Scholar
• Mackey BM. Lethal and sublethal effects of refrigeration, freezing and freeze-drying on micro-organisms. Soc Appl Bacteriol Symp Ser 1984;12:45–75
   PubMedGoogle Scholar
• WHO. General requirements for the sterility of biological substances. requirements for biological substances. Geneva, Switzerland: World Health Organization; 1973:22
   Google Scholar
• Castle P. European Pharmacopoeia (EP), USDA and MAFF standards – will they ever be harmonised under the VICH umbrella? Dev Biol (Basel) 2005;121:227–34
   PubMedGoogle Scholar
• Kassaza K, Orikiriza P, Llosa A, et al. Lowenstein–Jensen selective medium for reducing contamination in Mycobacterium tuberculosis culture. J Clin Microbiol 2014;52:2671–3
   PubMed Web of Science ®Google Scholar
• Wright D, Muggleton PW, Griffiths MI. Evaluation of the stability of dried BCG vaccine. Tubercle 1972;53:92–9
   PubMedGoogle Scholar
• Ungar J, Muggleton PW, Dudley JA, Griffiths MI. Preparation and properties of a freeze-dried B.C.G. vaccine of increased stability. Br Med J 1962;2:1086–9
   PubMedGoogle Scholar
• Ho MM, Southern J, Kang HN, Knezevic I. WHO Informal Consultation on standardization and evaluation of BCG vaccines Geneva, Switzerland 22–23 September 2009. Vaccine 2010;28:6945–50
   PubMedGoogle Scholar
• Howard MD, Lu X, Jay M, Dziubla TD. Optimization of the lyophilization process for long-term stability of solid–lipid nanoparticles. Drug Dev Ind Pharm 2012;38:1270–9
   PubMed Web of Science ®Google Scholar
• Hartung A, Knoell M, Schmidt U, Langguth P. Role of continuous moisture profile monitoring by inline NIR spectroscopy during fluid bed granulation of an Enalapril formulation. Drug Dev Ind Pharm 2011;37:274–80
   PubMed Web of Science ®Google Scholar
• ElKasabgy NA, Elsayed I, Elshafeey AH. Design of lipotomes as a novel dual functioning nanocarrier for bioavailability enhancement of lacidipine: in vitro and in vivo characterization. Int J Pharm 2014;472:369–79
   PubMed Web of Science ®Google Scholar
• Farmer P, Muggleton PW, Ungar J. Freeze-dried B.C.G. vaccine; methods adopted in preparation of a standard product. Br Med J 1956;2:568–71
   PubMed Web of Science ®Google Scholar
• FDA. International Conference on Harmonisation; stability data package for registration applications in climatic zones III and IV; stability testing of new drug substances and products; availability. Notice. Fed Regist 2003;68:65717–8
   PubMedGoogle Scholar
• FDA. International Conference on Harmonisation; guidance on Q1A stability testing of new drug substances and products; availability. Notice. Fed Regist 2001;66:56332–3
   PubMedGoogle Scholar
• Schofield TL. Vaccine stability study design and analysis to support product licensure. Biologicals 2009;37:387–96; discussion 421–3
   PubMed Web of Science ®Google Scholar
• FDA. International Conference on Harmonisation; evaluation of stability data; availability. Notice. Fed Regist 2004;69:32010–11
   PubMedGoogle Scholar
• Shin J, Smith D, Southern J, Knezevic I. WHO/KFDA workshop on stability evaluation of vaccines, Seoul, Korea, 23–25 April 2008. Biologicals 2009;37:435–44; discussion 21–3
   PubMedGoogle Scholar
• Nei T, Souzu H, Araki T. Effect of residual moisture content on the survival of freeze-dried bacteria during storage under various conditions. Cryobiology 1966;2:276–9
   PubMed Web of Science ®Google Scholar
• Behr MA. BCG – different strains, different vaccines? Lancet Infect Dis 2002;2:86–92
   PubMed Web of Science ®Google Scholar
• Freudenstein H, Passing H. Standardization of BCG vaccine by bacterial weight: variables influencing the uniformity of the product. J Biol Stand 1981;9:409–19
   PubMedGoogle Scholar
• Milstien JB, Gibson JJ. Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety. Bull World Health Organ 1990;68:93–108
   PubMed Web of Science ®Google Scholar
• Gheorghiu M, Lagrange PH. Viability, heat stability and immunogenicity of four BCG vaccines prepared from four different BCG strains. Ann Immunol (Paris) 1983;134C:125–47
   PubMedGoogle Scholar
• Mahmoud HI, El-Yazid MA, Tantawy LAE. Influence of residual moisture contents on the keeping quality of lyophilized brucella vaccines. J Egypt Vet Med Assoc 2014;74:305–12
   Google Scholar
• Cho C, Obayashi Y. Effect of adjuvant on preservability of dried BCG vaccine at 37 degrees C. Bull World Health Organ 1956;14:657–69
   PubMedGoogle Scholar
• WHO. Designs for in vitro assays of BCG products. Techn Guide. Geneva: World Health Organization; 1973:42
   Google Scholar